At a glance
ClinicalIndex Comparison RecordN/ACompleted· 71 enrolled
Drug / intervention
HeartPOD™ Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients: A Prospective, Multi-center, Non-randomized, Open Label Study.
In Brief
A clinical study evaluating HeartPOD™ System for Heart Failure. Completed, enrolled 71 participants across 7 sites in 3 countries.
Detailed Summary
This study is a feasibility study of the HeartPOD™ Heart Failure Management System with DynamicRx® (HeartPOD system) in patients with severe chronic congestive heart failure. The device being studied in this trial monitors heart function and alerts the patient and physician of necessary changes to medication. The study will assess the safety, reliability, and preliminary efficacy of the HeartPOD™ system.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
CountriesAustralia, New Zealand, United States
Collaborators--
Timeline
N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMar 2005
First PostedOct 2007
Primary CompletionJun 2008
TodayJul 2026
First PostedOct 23, 2007
Enrollment StartMar 1, 2005
Primary CompletionJun 1, 2008
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 18.7 years ago
Interventions
HeartPOD™ Systemdevice
HeartPOD™ device with DynamicRx® automatically measures left heart pressures throughout the day.